Free shipping on all orders over $ 500

H-89 Dihydrochloride

Cat. No. M1729
H-89 Dihydrochloride Structure
Synonym:

H-89 2HCl

Size Price Availability Quantity
5mg USD 40  USD40 In stock
10mg USD 60  USD60 In stock
25mg USD 130  USD130 In stock
50mg USD 240  USD240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

H-89 dihydrochloride is an inhibitor of PKA and MSK, inhibits cyclic-AMP response element binding protein-mediated MAPK phosphatase-1 induction by lipopolysaccharide. The Ki value is 48 nM for PKA inhibitor. H-89 having a relatively large number of PKA-independent effects which may seriously compromise interpretation of data, and it also inhibits at least 8 other kinases. As we recognized its kinase inhibiting properties, H89 should not be used as the single source of evidence of PKA involvement, it should be used in conjunction with other PKA inhibitors, such as Rp-cAMPS or PKA analogs.

Protocol (for reference only)
Cell Experiment
Cell lines Hela cells
Preparation method Choline uptake. Choline uptake was measured as described.Briefly. cells grown on colleen-coated plastic sheets, were preincubated for 30 min with medium containing H-89 or no supplements ascontrol, After preincubation, cells were immersed in medium with or without H-89, containing choline(5μCi/ml), After different times, cells were washed throughly with 58mmol/l choline chloride in PBS. Finally, uptake and incorpration of [H] choline were determined by liquid scintillation counting. background radioactivity was measured by repeating the experiment at 4℃.
Concentrations 0~100μM
Incubation time 1 h
Animal Experiment
Animal models Adult male Sprague-Dawley rats model
Formulation 5% DMSO in 0.9% sterile saline
Dosages 20 mg/kg or 200mg/kg twice daily
Administration oral gavage
Chemical Information
Molecular Weight 519.28
Formula C20H20BrN3O2S.2HCl
CAS Number 130964-39-5
Solubility (25°C) DMSO 54 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Lochner et al. Cardiovasc Drug Rev. The many faces of H89: a review.

[2] Davis MA, et al. J Pharmacol Exp Ther. Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89 (N-(2-[p-bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide).

[3] Geilen CC, et al. FEBS Lett. A selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulfonamide (H-89), inhibits phosphatidylcholine biosynthesis in HeLa cells.

Related PKA Products
Malantide

Malantide is a synthetic dodecapeptide derived from the site phosphorylated by cAMP-dependent protein kinase (PKA) on the β-subunit of phosphorylase kinase.

PKI (14-24)amide TFA

PKI (14-24)amide TFA is a potent PKA inhibitor.

PKA Inhibitor Fragment (6-22) amide

PKA Inhibitor Fragment (6-22) amide is an inhibitor of cAMP-dependent protein kinase A (PKA), with a Ki of 2.8 nM.

PKI (14-24)amide

PKI (14-24)amide is a potent PKA inhibitor.

H1-7 (histone H1 phosphorylation site), PKA Substrate

H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate.

  Catalog
Abmole Inhibitor Catalog




Keywords: H-89 Dihydrochloride, H-89 2HCl supplier, PKA, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.